Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation

References

• Josephson MA . Monitoring and managing graft health in the kidney transplant recipient. Clin. J. Am. Soc. Nephrol.6(7), 1774–1780 (2011).
   PubMed Web of Science ®Google Scholar
• DeRoos LJ , MarreroWJ , TapperEBet al. Estimated association between organ availability and presumed consent in solid organ transplant. JAMA Netw. Open2(10), e1912431 (2019).
   PubMed Web of Science ®Google Scholar
• Bandari J , FullerTW , Turnerli RM , D’AgostinoLA. Renal biopsy for medical renal disease: indications and contraindications. Can. J. Urol.23(1), 8121–8126 (2016).
   PubMed Web of Science ®Google Scholar
• Dutta R , OkhunovZ , VernezSLet al. Cost comparisons between different techniques of percutaneous renal biopsy for small renal masses. J. Endourol.30(Suppl. 1), S28–S33 (2016).
   PubMedGoogle Scholar
• Bloom RD , BrombergJS , PoggioEDet al. Cell-free DNA and active rejection in kidney allografts. J. Am. Sci. Nephrol.28(7), 2221–2232 (2017).
   PubMed Web of Science ®Google Scholar
• Bu L , GuptaG , PaiAet al. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study. Kidney Int.101(4), 793–803 (2022).
   PubMed Web of Science ®Google Scholar
• Halloran PF , ReeveJ , Madill-ThomsenKSet al. Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: results from the Trifecta study. Transplantation107(3), 709–719 (2023).
   PubMed Web of Science ®Google Scholar
• Gielis EM , LedeganckKJ , DeWinter BYet al. Cell-free DNA: an upcoming biomarker in transplantation. Am. J. Transplant.15(10), 2541–2551 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang H , ZhengC , LiXet al. Diagnostic performance of donor-derived plasma cell-free DNA fraction for antibody-mediated rejection in post renal transplant recipients: a prospective observational study. Front. Immunol.11, 342 (2020).
   PubMed Web of Science ®Google Scholar
• Oellerich M , ShipkovaM , AsendorfTet al. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study. Am. J. Transplant.19(11), 3087–3099 (2019).
   PubMed Web of Science ®Google Scholar
• Sigdel T , ArchilaF , ConstantinTet al. Optimizing detection of kidney transplant injury by assessment of donor-derived cell-Free DNA via massively multiplex PCR. JCM8(1), 19 (2018).
   Google Scholar
• Huang E , SethiS , PengAet al. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients. Am. J. Transplant.19(6), 1663–1670 (2019).
   PubMed Web of Science ®Google Scholar
• Dauber E , KollmannD , KozakowskiNet al. Quantitative PCR of INDEL s to measure donor-derived cell-free DNA – a potential method to detect acute rejection in kidney transplantation: a pilot study. Transpl. Int.33(3), 298–309 (2020).
   PubMed Web of Science ®Google Scholar
• Halloran PF , ReeveJ , Madill-ThomsenKSet al. The Trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies. J. Am. Sci. Nephrol.33(2), 387–400 (2022).
   PubMed Web of Science ®Google Scholar
• Sigdel TK , VitaloneMJ , TranTQet al. A rapid noninvasive assay for the detection of renal transplant Injury. Transplantation96(1), 97–101 (2013).
   PubMed Web of Science ®Google Scholar
• Kellum JA , RomagnaniP , AshuntantangG , RoncoC , ZarbockA , AndersH-J. Acute kidney injury. Nat. Rev. Dis. Primers7(1), 52 (2021).
   PubMed Web of Science ®Google Scholar
• Kumar N , RanaR , RanaDS , GuptaA , SachdevaMP. Donor-derived cell-free DNA to diagnose graft rejection post-transplant: past, present and future. Transplantology2(3), 348–361 (2021).
   Google Scholar
• Thongprayoon C , VaitlaP , CraiciIMet al. The use of donor-derived cell-free DNA for assessment of allograft rejection and injury status. J. Clin. Med.9(5), 1480 (2020).
   PubMed Web of Science ®Google Scholar
• Shen J , GuoL , YanPet al. Prognostic value of the donor-derived cell-free DNA assay in acute renal rejection therapy: aprospective cohort study. Clin. Transplant.34(10), e14053 (2020).
   PubMed Web of Science ®Google Scholar
• Yang JYC , SarwalRD , SigdelTKet al. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection. Sci. Transl. Med.12(535), eaba2501 (2020).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov . Urine biomarker for kidney transplant rejection NCT05072951. https://classic.clinicaltrials.gov/ct2/show/NCT05072951
   Google Scholar
• Jordan SC , BunnapradistS , BrombergJSet al. Donor-derived cell-free DNA Identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients. Transplant. Direct4(9), e379 (2018).
   PubMedGoogle Scholar
• Wijtvliet VPWM , PlaekeP , AbramsSet al. Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis. Transpl. Int.33(12), 1626–1642 (2020).
   PubMed Web of Science ®Google Scholar
• Kant S , BrennanDC. Donor-derived cell-free DNA in kidney transplantation: origins, present and a look to the future. Medicina57(5), 482 (2021).
   PubMedGoogle Scholar
• Garg N , MandelbrotDA , ParajuliSet al. The clinical value of donor-derived cell-free DNA measurements in kidney transplantation. Transplant. Rev.35(4), 100649 (2021).
   Web of Science ®Google Scholar
• Moeller C , OrenD , RubinsteinGet al. Clinical utility of donor derived cell-free DNA in the multiorgan transplantation. J. Heart Lung Transplant.42(4), S234 (2023).
   Web of Science ®Google Scholar
• Puttarajappa CM , MehtaRB , RobertsMS , SmithKJ , HariharanS. Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers. Am. J. Transplant.21(1), 186–197 (2021).
   PubMed Web of Science ®Google Scholar
• First MR , LeeD , LewisP , RoseS. An economic analysis of the cost effectiveness of blood gene expression profiling in kidney transplant recipients. J. Health Med. Econ.3(1), 1–5 (2017).
   Google Scholar
• Pai A , SwanJT , WojciechowskiDet al. Clinical rationale for a routine testing schedule using donor-derived cell-free DNA after kidney transplantation. Ann. Transplant.26, e932249 (2021).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov . Evaluation of patient outcomes from the Kidney Allograft Outcomes AlloSure Registry (KOAR). https://classic.clinicaltrials.gov/ct2/show/NCT03326076
   Google Scholar
• Paul RS , AlmokayadI , CollinsA , RajD , JagadeesanM. Donor-derived cell-free DNA: advancing a novel assay to new heights in renal transplantation. Transplant. Direct7(3), e664 (2021).
   PubMed Web of Science ®Google Scholar
• Edwards RL , MenteerJ , LestzRM , Baxter-LoweLA. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches. Biomark. Med.16(5), 401–415 (2022).
   PubMed Web of Science ®Google Scholar
• Martuszewski A , PaluszkiewiczP , KrólM , BanasikM , KepinskaM. Donor-derived cell-free DNA in kidney transplantation as a potential rejection biomarker: a systematic literature review. J. Clin. Med.10(2), 193 (2021).
   PubMed Web of Science ®Google Scholar
• Dengu F . Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation. Transplant. Rev.34(3), 100542 (2020).
   Web of Science ®Google Scholar
• Yu SC , LeeSW , JiangPet al. High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. Clin. Chem.59(8), 1228–1237 (2013).
   PubMed Web of Science ®Google Scholar